Some have relabeled it as Pentadecapeptide Aringate or PDA (altering the acetate to an arginate) and are prescribing it for subcutaneous administration this way, when the confusion about its standing has led to a vivid oral capsule market for BPC in what seems to get a gray place of legality. https://carolynz467tuu0.wikirecognition.com/user